News from the FDA/CDC

Just the FRAX: National fracture risks estimated


 

Adults aged 40 years and over have a mean 10-year risk of 5.3% for major osteoporotic fracture, according to the National Center for Health Statistics.

That risk includes a 10-year probability of 0.5% for hip fracture, based on estimates using the FRAX algorithm. These nationally representative estimates, the first to use the FRAX algorithm in this population, are based on 2013-2014 data from the National Health and Nutrition Examination Survey and show that the adjusted mean risks for those aged 50 years and over are 7.4% for major osteoporotic fracture and 0.9% for hip fracture, the NCHS reported.

Mean FRAX-based 10-year probability of fracture, 2013-2014
The 10-year probabilities vary significantly by race and Hispanic origin: Non-Hispanic whites have the highest risks, at 6.6%, for major fracture and 0.67% for hip fracture, compared with 3.4% and 0.42%, respectively, for non-Hispanic Asians, 3.2% and 0.3% for Hispanics, and 2.25% and 0. 11% for non-Hispanic blacks, the NCHS said.

The risk estimates in this analysis agree in large part with guidelines from the National Osteoporosis Foundation, which “use elevated FRAX scores in combination with low bone mass to define treatment eligibility,” the investigators said. FRAX-based findings, they noted, may provide “a more global evaluation of fracture risk than can be obtained from estimates based on [bone mineral density] alone.”

Recommended Reading

NAMS hormone therapy guidelines stress individualized treatment
MDedge Endocrinology
Guideline: Supplemental, dietary calcium both heart safe
MDedge Endocrinology
VIDEO: ACR recommendations for glucocorticoid-induced osteoporosis unveiled
MDedge Endocrinology
VIDEO: Denosumab trumps risedronate in bone building for glucocorticoid-induced osteoporosis
MDedge Endocrinology
Study highlights need to address vitamin D deficiency in epilepsy patients
MDedge Endocrinology
Bone fractures more likely to occur in psoriasis, PsA patients
MDedge Endocrinology
Targeting Paget’s bone symptoms supported in long-term trial
MDedge Endocrinology
Large, intermittent vitamin D doses may increase fracture, fall risk in elderly
MDedge Endocrinology
New guidance: Bone health is front and center in functional hypothalamic amenorrhea care
MDedge Endocrinology
Study shows no adverse events with long-term denosumab in postmenopausal women
MDedge Endocrinology